Image: RollingNews.ie Image: RollingNews.ie AMERICAN PHARMACEUTICAL COMPANY Perrigo has failed in a High Court bid to overturn a €1.64 billion Irish tax demand.
The revised demand relates to the 2013 sale to Biogen of Perrigo’s 50% interest in the intellectual property linked to multiple sclerosis drug Tysabri. It also appealed the decision to the Tax Appeal Commission , where a decision on the matter was stayed last year pending resolution of the High Court action.
When is tax not a tax ? When it's an Apple.
When are the government expected to overturn this decision?
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more: